Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP312976.RAWHEWc1pqAJA10H6IV4QyDSo8isxjHAOGlI4301moIGs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP312976.RAWHEWc1pqAJA10H6IV4QyDSo8isxjHAOGlI4301moIGs130_assertion type Assertion NP312976.RAWHEWc1pqAJA10H6IV4QyDSo8isxjHAOGlI4301moIGs130_head.
- NP312976.RAWHEWc1pqAJA10H6IV4QyDSo8isxjHAOGlI4301moIGs130_assertion description "[The high frequency of TP53 mutations in triple negative breast cancer (TNBC: negative for estrogen receptor, progesterone receptor, and HER2) make Chk1 an attractive therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312976.RAWHEWc1pqAJA10H6IV4QyDSo8isxjHAOGlI4301moIGs130_provenance.
- NP312976.RAWHEWc1pqAJA10H6IV4QyDSo8isxjHAOGlI4301moIGs130_assertion evidence source_evidence_literature NP312976.RAWHEWc1pqAJA10H6IV4QyDSo8isxjHAOGlI4301moIGs130_provenance.
- NP312976.RAWHEWc1pqAJA10H6IV4QyDSo8isxjHAOGlI4301moIGs130_assertion SIO_000772 23242585 NP312976.RAWHEWc1pqAJA10H6IV4QyDSo8isxjHAOGlI4301moIGs130_provenance.
- NP312976.RAWHEWc1pqAJA10H6IV4QyDSo8isxjHAOGlI4301moIGs130_assertion wasDerivedFrom befree-20150227 NP312976.RAWHEWc1pqAJA10H6IV4QyDSo8isxjHAOGlI4301moIGs130_provenance.
- NP312976.RAWHEWc1pqAJA10H6IV4QyDSo8isxjHAOGlI4301moIGs130_assertion wasGeneratedBy ECO_0000203 NP312976.RAWHEWc1pqAJA10H6IV4QyDSo8isxjHAOGlI4301moIGs130_provenance.